BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31438887)

  • 1. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
    Gomez-Acevedo H; Patterson JD; Sardar S; Gokden M; Das BC; Ussery DW; Rodriguez A
    BMC Cancer; 2019 Aug; 19(1):827. PubMed ID: 31438887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
    Trieu V; Aulet RM; Ciolino A; Rimash T
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
    McHugh KE; Policarpio-Nicolas MLC
    Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse spinal cord metastasis after resection of SMARCB1 sinonasal carcinoma manifesting with a right foot drop-a case report.
    da Silva MA; Bentes RGL; Teixeira HS; Carvalho BM; Queiroz ALG; Schmid MF; Lima KDF; Ferreira WSM; Campos CMS; Neto MR; Baeta AM
    Spinal Cord Ser Cases; 2022 Jul; 8(1):64. PubMed ID: 35778377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma].
    Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
    [No Abstract]   [Full Text] [Related]  

  • 8. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
    AlMadan NM; AlEssa EA; AlGhamdi DA
    Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decompression of Cavernous Sinus for Trigeminal Neuropathic Pain From Perineural Spread of Tumor: 2-Dimensional Operative Video.
    Morris TW; Hundley KN; Thomas KO; Lockhart EC; Rodriguez A; Day JD
    Oper Neurosurg (Hagerstown); 2020 Sep; 19(3):E304-E305. PubMed ID: 32147730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
    Parsel SM; Jawad BA; McCoul ED
    World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma.
    Park KK; Yang SI; Seo KW; Kim YO; Yoon KY
    World J Surg Oncol; 2012 May; 10():74. PubMed ID: 22553956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptomeningeal carcinomatosis from ethmoid sinus adenocarcinoma.
    Espitalier F; Michel G; Mourrain-Langlois E; Lebouvier T; Bord E; Ferron C; Malard O
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Feb; 131(1):49-51. PubMed ID: 23273418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
    Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
    Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sphenoid sinus neoplasms: a report of four cases with common clinical presentation treated with transsphenoidal surgery and adjuvant therapies.
    Esposito F; Kelly DF; Vinters HV; DeSalles AA; Sercarz J; Gorgulhos AA
    J Neurooncol; 2006 Feb; 76(3):299-306. PubMed ID: 16163447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
    Allard FD; Bell D; Stelow EB
    Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
    Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
    Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
    Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
    J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.